Latka logo
I3 Precision logo

I3 Precision

Singapore, Central Region, Singapore

2021 Revenue

$218.5K

Funding

$0

Team

5

Founded

2011

I3 Precision Revenue (2021)

I3 Precision generated $218.5K in revenue in 2021.

Developer of a medical technology designed to reduce medication errors. The company's technology minimizes medication errors at different stages of the pharmacy process and medication regime and uses advanced imaging algorithms, enabling healthcare professionals to generate, verify and identify medications during preparation, dispensing and administration.

Last updated

I3 Precision Revenue

In 2021, I3 Precision's revenue reached $218.5K.

I3 Precision Revenue GrowthReported revenue / ARR over time$0$50K$100K$150K$200K$250K201120132015201720192021$0$218.5KSource: GetLatka.com
YearMilestoneSource
2021I3 Precision Hit $218.5k revenue in April 2021Not recorded
2011Launched with $0 revenue

I3 Precision Valuation, Funding Rounds

We do not have funding information about I3 Precision yet.

No funding has been reported for I3 Precision yet.

Founder / CEO

Customers

We do not have customer count information for I3 Precision yet.

I3 Precision Employees & Team Size

I3 Precision employs approximately 5 people as of 2026, including 1 sales reps that carry a quota.

I3 Precision Team GrowthReported headcount over time0134562011201320152017201920210055Source: GetLatka.com
YearMilestoneSource
2021Reached 5 employees (April 2021)Not recorded

Frequently Asked Questions about I3 Precision

Is I3 Precision still operating?

No. I3 Precision has shut down.

What is I3 Precision's revenue?

As of 2021, I3 Precision generated $218.5K in revenue.

Who founded I3 Precision?

I3 Precision was founded by Teck Lim.

How many employees does I3 Precision have?

As of 2021, I3 Precision had 5 employees.

Where is I3 Precision headquartered?

I3 Precision is headquartered in Singapore, Central Region, Singapore.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile